Sign in

CIK 0001752828

  • Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831702591
Phone
+1 908-768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-04-13 Fletcher Kyle Shares withheld for taxes −20 $4.11 $82 21,085
2024-03-15 Fletcher Kyle Shares withheld for taxes −617 $5.68 $4K 21,105
2024-02-17 Fletcher Kyle Shares withheld for taxes −39,571 $0.43 $17K 217,228
2024-02-16 Fletcher Kyle Grant or award · Stock Option Grant (Right to Buy) +164,171 164,171
2023-04-13 Fletcher Kyle Shares withheld for taxes −201 $0.71 $144 256,799
2023-03-15 Fletcher Kyle Shares withheld for taxes −2,170 $0.63 $1K 257,000
2023-02-17 Fletcher Kyle Grant or award +225,000 259,170
2022-11-16 Fletcher Kyle General Counsel Shares withheld for taxes −1,262 $1.89 $2K 34,170
2022-07-13 Fletcher Kyle General Counsel Grant or award +2,297 35,432
2022-07-13 Fletcher Kyle General Counsel Grant or award · Stock Option (Right to Buy) +6,735 6,735
2022-07-13 Fletcher Kyle General Counsel Grant or award · Stock Option (Right to Buy) +125,000 125,000

Page 1 of 1 · 11 trades